Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Restenosis after PCI. Part 2: prevention and therapy.

Literature DB >> 21989052

Restenosis after PCI. Part 2: prevention and therapy.

J Wouter Jukema¹, Tarek A N Ahmed, Jeffrey J W Verschuren, Paul H A Quax.

Abstract

The techniques and materials used during percutaneous coronary intervention have advanced considerably over the past 3 decades, yet restenosis remains one of the major drawbacks of this procedure. Many innovative technologies, including drug-eluting stents, with or without specific polymers, and fully biodegradable stents have been and continue to be developed in the search for a safe and effective antirestenosis therapy. Remarkable advances in stent design and nanoparticle delivery systems ('nanovehicles') have already fueled revolutionary changes in the prevention and treatment of in-stent restenosis. In this Review we provide an overview of the latest innovations for optimizing outcomes of coronary stenting, and up-to-date information about prevention and treatment of in-stent restenosis.

Entities: Chemical Disease Gene

Mesh：

Year: 2011 PMID： 21989052 DOI： 10.1038/nrcardio.2011.148

Source DB: PubMed Journal: Nat Rev Cardiol ISSN： 1759-5002 Impact factor: 32.419

129 in total

1. Treatment of drug-eluting stent restenosis.

Authors: Marco A Costa
Journal: Am Heart J Date: 2007-04 Impact factor: 4.749

2. Local delivery of anti-monocyte chemoattractant protein-1 by gene-eluting stents attenuates in-stent stenosis in rabbits and monkeys.

Authors: Kensuke Egashira; Kaku Nakano; Kisho Ohtani; Kouta Funakoshi; Gang Zhao; Yoshiko Ihara; Jun-Ichiro Koga; Satoshi Kimura; Ryuji Tominaga; Kenji Sunagawa
Journal: Arterioscler Thromb Vasc Biol Date: 2007-09-20 Impact factor: 8.311

3. Comparison of titanium-nitride-oxide-coated stents with zotarolimus-eluting stents for coronary revascularization a randomized controlled trial.

Authors: Thomas Pilgrim; Lorenz Räber; Andreas Limacher; Lukas Löffel; Peter Wenaweser; Stéphane Cook; Jean-Christophe Stauffer; Mario Togni; Rolf Vogel; Ali Garachemani; Aris Moschovitis; Ahmed A Khattab; Christian Seiler; Bernhard Meier; Peter Jüni; Stephan Windecker
Journal: JACC Cardiovasc Interv Date: 2011-06 Impact factor: 11.195

4. Peri-implant bone formation and implant integration strength of peptide-modified p(AAM-co-EG/AAC) interpenetrating polymer network-coated titanium implants.

Authors: Thomas A Barber; James E Ho; Aladino De Ranieri; Amarjit S Virdi; Dale R Sumner; Kevin E Healy
Journal: J Biomed Mater Res A Date: 2007-02 Impact factor: 4.396

5. Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields.

Authors: Michael Chorny; Ilia Fishbein; Benjamin B Yellen; Ivan S Alferiev; Marina Bakay; Srinivas Ganta; Richard Adamo; Mansoor Amiji; Gary Friedman; Robert J Levy
Journal: Proc Natl Acad Sci U S A Date: 2010-04-19 Impact factor: 11.205

6. Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: impact on restenosis.

Authors: Teruo Inoue; Masataka Sata; Yutaka Hikichi; Ryoichi Sohma; Daiju Fukuda; Toshihiko Uchida; Minoru Shimizu; Hiroshi Komoda; Koichi Node
Journal: Circulation Date: 2007-01-29 Impact factor: 29.690

7. Comparative assessment of drug-eluting balloons in an advanced porcine model of coronary restenosis.

Authors: M Joner; R A Byrne; J-M Lapointe; P W Radke; G Bayer; K Steigerwald; E Wittchow
Journal: Thromb Haemost Date: 2011-02-08 Impact factor: 5.249

8. Human placental ectonucleoside triphosphate diphosphohydrolase gene transfer via gelatin-coated stents prevents in-stent thrombosis.

Authors: Yasuhiro Takemoto; Hiroyuki Kawata; Tsunenari Soeda; Keiichi Imagawa; Satoshi Somekawa; Yukiji Takeda; Shiro Uemura; Masanori Matsumoto; Yoshihiro Fujimura; Jun-ichiro Jo; Yu Kimura; Yasuhiko Tabata; Yoshihiko Saito
Journal: Arterioscler Thromb Vasc Biol Date: 2009-03-26 Impact factor: 8.311

9. Novel gene silencer pyrrole-imidazole polyamide targeting lectin-like oxidized low-density lipoprotein receptor-1 attenuates restenosis of the artery after injury.

Authors: En-Hui Yao; Noboru Fukuda; Takahiro Ueno; Hiroyuki Matsuda; Koichi Matsumoto; Hiroki Nagase; Yoshiaki Matsumoto; Ayako Takasaka; Kazuo Serie; Hiroshi Sugiyama; Tatsuya Sawamura
Journal: Hypertension Date: 2008-06-02 Impact factor: 10.190

10. Comparison of in vivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everolimus-eluting cobalt chromium coronary stent: insights from the ABSORB and SPIRIT trials.

Authors: Shuzou Tanimoto; Patrick W Serruys; Leif Thuesen; Dariusz Dudek; Bernard de Bruyne; Bernard Chevalier; John A Ormiston
Journal: Catheter Cardiovasc Interv Date: 2007-10-01 Impact factor: 2.692

29 in total

Review 1. Secondary revascularization after CABG surgery.

Authors: Javier Escaned
Journal: Nat Rev Cardiol Date: 2012-07-10 Impact factor: 32.419

2. Unimolecular Micelle-Based Hybrid System for Perivascular Drug Delivery Produces Long-Term Efficacy for Neointima Attenuation in Rats.

Authors: Guojun Chen; Xudong Shi; Bowen Wang; Ruosen Xie; Lian-Wang Guo; Shaoqin Gong; K Craig Kent
Journal: Biomacromolecules Date: 2017-06-14 Impact factor: 6.988

3. Computational Modeling of Inflammation and Wound Healing.

Authors: Cordelia Ziraldo; Qi Mi; Gary An; Yoram Vodovotz
Journal: Adv Wound Care (New Rochelle) Date: 2013-11 Impact factor: 4.730

4. RECK suppresses interleukin-17/TRAF3IP2-mediated MMP-13 activation and human aortic smooth muscle cell migration and proliferation.

Authors: Srinivas Mummidi; Nitin A Das; Andrea J Carpenter; Tadashi Yoshida; Manjunath Yariswamy; Ricardo Mostany; Reza Izadpanah; Yusuke Higashi; Sergiy Sukhanov; Makoto Noda; Ulrich Siebenlist; Randy S Rector; Bysani Chandrasekar
Journal: J Cell Physiol Date: 2019-05-09 Impact factor: 6.384

Review 5. Vein graft failure: from pathophysiology to clinical outcomes.

Authors: Margreet R de Vries; Karin H Simons; J Wouter Jukema; Jerry Braun; Paul H A Quax
Journal: Nat Rev Cardiol Date: 2016-05-19 Impact factor: 32.419

Review 6. Long Noncoding RNAs in Atherosclerosis and Vascular Injury: Pathobiology, Biomarkers, and Targets for Therapy.

Authors: Jacob B Pierce; Mark W Feinberg
Journal: Arterioscler Thromb Vasc Biol Date: 2020-07-23 Impact factor: 8.311

Review 7. A review on core-shell structured unimolecular nanoparticles for biomedical applications.

Authors: Guojun Chen; Yuyuan Wang; Ruosen Xie; Shaoqin Gong
Journal: Adv Drug Deliv Rev Date: 2018-07-20 Impact factor: 15.470

8. Amphiphilic macromolecule nanoassemblies suppress smooth muscle cell proliferation and platelet adhesion.

Authors: Jennifer W Chan; Daniel R Lewis; Latrisha K Petersen; Prabhas V Moghe; Kathryn E Uhrich
Journal: Biomaterials Date: 2016-01-04 Impact factor: 12.479

9. Systematic testing of literature reported genetic variation associated with coronary restenosis: results of the GENDER Study.

Authors: Jeffrey J W Verschuren; Stella Trompet; Iris Postmus; M Lourdes Sampietro; Bastiaan T Heijmans; Jeanine J Houwing-Duistermaat; P Eline Slagboom; J Wouter Jukema
Journal: PLoS One Date: 2012-08-03 Impact factor: 3.240

10. Comparison of 9-Month Angiographic Follow-Up and Long-Term Clinical Outcomes of Biodegradable Polymer Drug-Eluting Stents and Second-Generation Durable Polymer Drug-Eluting Stents in Patients Undergoing Single Coronary Artery Stenting.

Authors: Ming-Lung Tsai; Ming-Jer Hsieh; Chun-Chi Chen; Shang-Hung Chang; Chao-Yung Wang; Dong-Yi Chen; Chia-Hung Yang; Jih-Kai Yeh; Ming-Yun Ho; I-Chang Hsieh
Journal: Acta Cardiol Sin Date: 2020-03 Impact factor: 2.672